Heparin-LL37 complexes are less cytotoxic for human dental pulp cells and have undiminished antimicrobial and LPS-neutralizing abilities.

作者: K. Yoshida , S. Suzuki , M. Kawada‐Matsuo , J. Nakanishi , S. Hirata‐Tsuchiya

DOI: 10.1111/IEJ.13130

关键词:

摘要: AIM To investigate whether glycosaminoglycans (GAGs) binding to high-dose LL37 eliminates its cytotoxicity dental pulp cells (hDPCs) whilst retaining undiminished antimicrobial and LPS-neutralizing abilities. METHODOLOGY hDPCs were stimulated with varying concentrations of LL37, their cell viability was analysed by MTT. Then, (10 μmol L-1 ) bound three GAGs, heparin, chondroitin sulphate hyaluronic acid, cytotoxic effects on evaluated compared. Furthermore, the ability heparin (5 μg mL-1 )-LL37 complexes, which found be less for ability, investigated. Statistical analysis performed using one-way variance (anova), followed Dunnett's test. P values below 0.05 considered significant. RESULTS significantly reduced in a dose-dependent manner (P < 0.01). within limited concentration range (2~6 μg mL-1 eliminated (P < 0.01) exerting potent against Streptococcus mutans, sobrinus, salivarius, Aggegatibacter actinomycetemcomitans Escherichia coli. exhibited similar functions (P < 0.01); however, effective highly restricted (3 μg mL-1 ). acid unable abrogate even at higher (10 100 μg mL-1 Moreover, exogenous addition LPS dose-dependently amount precipitated heparin-LL37 agarose beads (P < 0.01), released simultaneously neutralized pro-inflammatory macrophages CONCLUSIONS Heparin-LL37 complexes generated suitable ratios are easy make, broad-range materials that can neutralize providing accordance free LPS. They may potential treatment save tissue from acute inflammation exacerbated invading bacteria they release.

参考文章(52)
Gudmundur Bergsson, Emer P. Reeves, Paul McNally, Sanjay H. Chotirmall, Catherine M. Greene, Peter Greally, Philip Murphy, Shane J. O'Neill, Noel G. McElvaney, LL-37 complexation with glycosaminoglycans in cystic fibrosis lungs inhibits antimicrobial activity, which can be restored by hypertonic saline. Journal of Immunology. ,vol. 183, pp. 543- 551 ,(2009) , 10.4049/JIMMUNOL.0803959
Mizuho Kittaka, Hideki Shiba, Mikihito Kajiya, Takako Fujita, Tomoyuki Iwata, Khung Rathvisal, Kazuhisa Ouhara, Katsuhiro Takeda, Tsuyoshi Fujita, Hitoshi Komatsuzawa, Hidemi Kurihara, The antimicrobial peptide LL37 promotes bone regeneration in a rat calvarial bone defect Peptides. ,vol. 46, pp. 136- 142 ,(2013) , 10.1016/J.PEPTIDES.2013.06.001
Mikihito Kajiya, Hideki Shiba, Hitoshi Komatsuzawa, Kazuhisa Ouhara, Tsuyoshi Fujita, Katsuhiro Takeda, Yuushi Uchida, Noriyoshi Mizuno, Hiroyuki Kawaguchi, Hidemi Kurihara, The Antimicrobial Peptide LL37 Induces the Migration of Human Pulp Cells: A Possible Adjunct for Regenerative Endodontics Journal of Endodontics. ,vol. 36, pp. 1009- 1013 ,(2010) , 10.1016/J.JOEN.2010.02.028
Jan Johansson, Gudmundur H. Gudmundsson, Martı́n E. Rottenberg, Kurt D. Berndt, Birgitta Agerberth, Conformation-dependent Antibacterial Activity of the Naturally Occurring Human Peptide LL-37 Journal of Biological Chemistry. ,vol. 273, pp. 3718- 3724 ,(1998) , 10.1074/JBC.273.6.3718
N. Y. Yount, M. R. Yeaman, Multidimensional signatures in antimicrobial peptides Proceedings of the National Academy of Sciences of the United States of America. ,vol. 101, pp. 7363- 7368 ,(2004) , 10.1073/PNAS.0401567101
Margherita Zanetti, Cathelicidins, multifunctional peptides of the innate immunity Journal of Leukocyte Biology. ,vol. 75, pp. 39- 48 ,(2004) , 10.1189/JLB.0403147
Kim A. Brogden, Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nature Reviews Microbiology. ,vol. 3, pp. 238- 250 ,(2005) , 10.1038/NRMICRO1098
Roman Jerala, Massimo Porro, Endotoxin neutralizing peptides Current Topics in Medicinal Chemistry. ,vol. 4, pp. 1173- 1184 ,(2004) , 10.2174/1568026043388079